DocGo Inc. Comprehensive Income
DocGo Inc. (DCGO) reported Comprehensive Income of -$15.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-17
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$15.90M.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$14.90M.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$134.12M.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$28.06M, a 536.16% decline year-over-year.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$181.23M, a 1018.61% decline from fiscal 2024.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $19.73M, a 159.52% increase from fiscal 2023.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $7.60M, a 78.50% decline from fiscal 2022.
- DocGo Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $35.36M, a 48.82% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.90M 10-Q · filed 2026-08-17 | -$30.80M 10-Q · filed 2026-08-17 | -$164.92M derived: sum of 3 quarters · filed 2026-08-17 | -$192.97M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$14.90M 10-Q · filed 2026-05-11 | -$149.02M derived: sum of 2 quarters · filed 2026-05-11 | -$177.08M derived: sum of 3 quarters · filed 2026-05-11 | -$187.23M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$134.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$162.17M derived: sum of 2 quarters · filed 2026-03-16 | -$172.32M derived: sum of 3 quarters · filed 2026-08-17 | -$181.23M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$28.06M 10-Q · filed 2025-11-10 | -$38.21M derived: sum of 2 quarters · filed 2026-08-17 | -$47.12M 10-Q · filed 2025-11-10 | -$51.47M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$10.15M 10-Q · filed 2026-08-17 | -$19.06M 10-Q · filed 2026-08-17 | -$23.42M derived: sum of 3 quarters · filed 2026-08-17 | -$16.98M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$8.91M 10-Q · filed 2026-05-11 | -$13.26M derived: sum of 2 quarters · filed 2026-05-11 | -$6.83M derived: sum of 3 quarters · filed 2026-05-11 | -$267.99K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.08M derived: sum of 2 quarters · filed 2026-03-16 | $8.64M derived: sum of 3 quarters · filed 2026-03-16 | $19.73M 10-K · filed 2026-03-16 |
| 2024-09-30 | $6.43M 10-Q · filed 2025-11-10 | $13.00M derived: sum of 2 quarters · filed 2025-11-10 | $24.08M 10-Q · filed 2025-11-10 | $32.33M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $6.56M 10-Q · filed 2025-08-07 | $17.65M 10-Q · filed 2025-08-07 | $25.90M derived: sum of 3 quarters · filed 2026-03-16 | $30.08M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $11.09M 10-Q · filed 2025-05-08 | $19.33M derived: sum of 2 quarters · filed 2026-03-16 | $23.52M derived: sum of 3 quarters · filed 2026-03-16 | $21.91M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $12.43M derived: sum of 2 quarters · filed 2026-03-16 | $10.82M derived: sum of 3 quarters · filed 2026-03-16 | $7.60M 10-K · filed 2026-03-16 |
| 2023-09-30 | $4.18M 10-Q · filed 2024-11-07 | $2.58M derived: sum of 2 quarters · filed 2024-11-07 | -$645.05K 10-Q · filed 2024-11-07 | $7.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$1.61M 10-Q · filed 2024-08-07 | -$4.83M 10-Q · filed 2024-08-07 | $3.76M derived: sum of 3 quarters · filed 2025-02-27 | $7.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$3.22M 10-Q · filed 2024-05-08 | $5.36M derived: sum of 2 quarters · filed 2025-02-27 | $8.77M derived: sum of 3 quarters · filed 2025-02-27 | $21.51M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $8.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.99M derived: sum of 2 quarters · filed 2025-02-27 | $24.73M derived: sum of 3 quarters · filed 2025-02-27 | $35.36M 10-K · filed 2025-02-27 |
| 2022-09-30 | $3.40M 10-Q · filed 2023-11-06 | $16.15M derived: sum of 2 quarters · filed 2023-11-06 | $26.77M 10-Q · filed 2023-11-06 | $50.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $12.75M 10-Q · filed 2023-08-08 | $23.37M 10-Q · filed 2023-08-08 | $46.77M derived: sum of 3 quarters · filed 2024-02-28 | $50.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $10.62M 10-Q · filed 2023-05-09 | $34.03M derived: sum of 2 quarters · filed 2024-02-28 | $37.61M derived: sum of 3 quarters · filed 2024-02-28 | $36.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $23.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $26.98M derived: sum of 2 quarters · filed 2024-02-28 | $25.43M derived: sum of 3 quarters · filed 2024-02-28 | $23.76M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.58M 10-Q · filed 2022-11-08 | $2.03M derived: sum of 2 quarters · filed 2022-11-08 | $354.78K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$1.55M 10-Q · filed 2022-08-09 | -$3.22M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$1.67M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$14.16M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |